Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment
Key facts
- Who runs it
- University of Nevada, Reno
- Where
- Reno, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 31 people enrolled
- Started
- 18 Jun 2024
- Ended
- 13 Sept 2024
- Type of study
- Interventional
- Treatments tested
- NJOY ACE commercial e-cigarette
- Record updated
- 13 May 2025
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- currently engaged in outpatient treatment the Mathewson Institute (medication, behavioral, or combination treatment) or other local treatment center
- aged 21+
- interested in switching from cigarettes to e-cigarettes, assessed by the item "Are you interested in replacing some or all of your cigarettes with e-cigarettes?"
- has a cellphone with an unlimited text message plan
- has had the same phone number for at least 1 month
- uses text messages at least once a week
- self-reports daily smoking
- records an exhaled air carbon monoxide (CO) level >6ppm at baseline study visit
- has the capacity to understand the participant materials and follow the study procedures (e.g. sufficient English language ability)
Who cannot take part
- Individuals who meet any the following criteria will not be enrolled in this study:
- have used an e-cigarette to quit smoking in the past month
- are currently pregnant or breast-feeding
Where in United States
- University of Nevada, RenoReno, United States
About the trial
What the trial wants to find out
The purpose of the proposed study is to examine the feasibility of integrating a smoking harm reduction program featuring provision of e-cigarettes and tailored instructions to switch into an existing substance use disorder treatment program. This longitudinal study includes three weeks of micro-surveys delivered via text messages to evaluate the intervention's feasibility and acceptability, gather initial effectiveness data, and understand participants' lived experience of smoking and vaping while engaged in substance use disorder treatment.
The group in the trial
- E-cigarette armTreatment being tested
Participants will receive the commercially available NJOY ACE e-cigarette, nicotine pods (2 of each available flavor, for a total of 4 pods), and tailored instructions to switch. Participants will use the ACE ad libitum for 14 days, reporting their cigarette use, e-cigarette use, mood, and nicotine crazing every day via text message surveys.
Treatment: NJOY ACE commercial e-cigarette
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in Substance Use Disorder Treatment
- Record updated
- 13 May 2025